Department of Health and Social Care written question – answered am ar 22 Ebrill 2024.
Baroness Ritchie of Downpatrick
Non-affiliated
To ask His Majesty's Government whether they intend to license the drug Lecanemab for the treatment of dementia and Alzheimer’s disease; and if so, when.
Lord Markham
The Parliamentary Under-Secretary for Health and Social Care
The Medicines and Healthcare products Regulatory Agency will review any marketing authorisation application received, and will consider the drug with regard to quality, safety and efficacy. We do not comment on application status or applications in progress, until a full and timely decision is made with consideration of the recommendation of Commission on Human Medicines as needed. We continue to advise that patients consult with their respective healthcare professionals regarding treatment and management options for dementia and Alzheimer’s disease.
Yes3 people think so
No2 people think not
Would you like to ask a question like this yourself? Use our Freedom of Information site.
